Aurobindo Pharma share news, announcements and annual reports
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Aurobindo Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Jul 2000 on NSE
Last close ₹1,681.40up ₹21.50 (1.30%)BSE ₹1,677.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,659.90.
30 Oct: open ₹1,652.00, high ₹1,687.00, low ₹1,647.20
52-week range of traded prices to 30 Oct 2026
₹1,091.20Low, 30 Oct 2025₹1,740.00High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹96,744 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.06
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,65057.5% delivered
Aurobindo Pharma share news and announcements
1,689 announcements, routine notices left out, newest first. Page 29 of 34.
May 2011
9 May · Meeting
Board of Directors of the Company at its meeting held on May 09, 2011 has inter-alia considered and approved the following: (1) To convene the Annual General Meeting of the Company on July 29, 2011. (2) The Register of Members and Share Transfer Books of the Company will be closed from July 22, 2011 to July 29, 2011 (both days inclusive) for the purpose of Annual General Meeting and for payment of dividend for the year 2010-11.9 May · Board meeting
Board of Directors of the Company at its Meeting held on May 09, 2011, has inter alia decided the following : In order to further strengthen and provide focus to the growing volume of APIs and Formulation Business, the Board has constituted a Re-structuring Committee to explore and evaluate possible growth linked restructuring options, inter alia, including spin-off or demerger or any other suitable form, with the ultimate objective of enhancing shareholders' value and customer satisfaction. The Restructuring Committee, consisting of directors including independent directors, will take all necessary steps and recommend the best options to the Board for consideration within a period of 3 months.9 May · Management
Board of Directors of the Company at the meeting held on May 09, 2011 has taken on record the resignation of Dr.K.Ramachandran as a Director of the Company.9 May · Dividend
Board of Directors of the Company at its meeting held on May 09, 2011 has considered and approved the final dividend at 100% (Re.1.00 per share of Re.1/- each) on the equity share capital of the Company for the year 2010-2011 has been recommended, subject to approval of members. The Company in the month of November, 2010 has paid an interim dividend of 100% (Rs. 5.00 per share of Rs. 5/- each) on the equity share capital of the Company for the year 2010-2011.9 May · Results
Consolidated Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 438148 lacs for year ending on 31-MAR-2011 against Rs. 357643 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 56345 lacs for the year ending on 31-MAR-2011 against Rs. 56340 lacs for the year ending on 31-MAR-2010.9 May · Results
Standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 413312 lacs for year ending on 31-MAR-2011 against Rs. 325227 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 59380 lacs for the year ending on 31-MAR-2011 against Rs. 52576 lacs for the year ending on 31-MAR-2010.
Apr 2011
29 Apr · Board meeting
Inter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2011 and recommendation of final dividend, if any, for the financial year ended March 31, 2011.
Mar 2011
3 Mar · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2010 A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2011
5 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 115661 lacs for quarter ending on 31-DEC-2010 against Rs. 81106 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 18385 lacs for the quarter ending on 31-DEC-2010 against Rs. 14826 lacs for the quarter ending on 31-DEC-2009.5 Feb · Results
Consolidated Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 119220 lacs for quarter ending on 31-DEC-2010 against Rs. 91524 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 18863 lacs for the quarter ending on 31-DEC-2010 against Rs. 17177 lacs for the quarter ending on 31-DEC-2009.
Jan 2011
24 Jan · Board meeting
To consider inter alia, the Un-Audited Financial Results of the Company for the quarter ended December 31, 2010.
Dec 2010
30 Dec · Business
Compensation Committee of the Board at the meeting held on December 30, 2010 has made allotment of 2,700 Equity Shares of Rs.5/- each at a premium of Rs.357.60 per share under ESOP-2004 Scheme of the Company. Consequent to the allotment the paid up share capital of the Company has increased from 58221558 Equity Shares of Rs.5/- each to 58224258 Equity Shares of Rs.5/-each.23 Dec · Corporate action
Company has fixed February 11, 2011 as the record for the purpose of sub-division of shares.23 Dec · Meeting
At the Extraordinary General Meeting of the Company held on December 23, 2010, the shareholders have approved the sub-division of one equity share of the face value of Rs.5/- each in the Company into five equity shares of the face value of Re.1/-each.
Nov 2010
25 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Nov · Dividend
Board of Directors of the Company at its meeting held on November 03, 2010 has approved payment of an Interim Dividend @ 100% i.e., Rs.5/- (Rupees five only) per Equity Share of Rs.5/- (Rupees five only) each to the members of the Company for the Current Financial Year 2010-11.3 Nov · Corporate action
At the meeting of the Board of Directors of the Company held on November 03, 2010, the Board has approved the Sub-division of equity shares of the face value of Rs. 5/- each in the Company into shares with the face value of Rs. 1/- each. The sub-division would be subject to the approval of the shareholders at the proposed Extraordinary General Meeting and such other approvals as may be necessary.3 Nov · Results
Consolidated Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 111262 lacs for quarter ending on 30-SEP-2010 against Rs. 88264 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 19832 lacs for the quarter ending on 30-SEP-2010 against Rs. 10319 lacs for the quarter ending on 30-SEP-2009.3 Nov · Results
Standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 105043 lacs for quarter ending on 30-SEP-2010 against Rs. 82631 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 21403 lacs for the quarter ending on 30-SEP-2010 against Rs. 12829 lacs for the quarter ending on 30-SEP-2009.
Oct 2010
29 Oct · Corporate action
Company has fixed November 12, 2010 as the record date for the purpose of ascertaining the eligibility of shareholders for payment of interim Dividend, if any, to be declared by the Board of Directors at its meeting to be held on November 03, 2010.21 Oct · Board meeting
To consider inter-alia, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2010.
Sep 2010
23 Sep · Meeting
At the Annual General Meeting of the Company held on September 23, 2010, the Members have approved the following: (1) Audited Annual Accounts of the Company for the year ended March 31, 2010. (2) Final Dividend @ 40% i.e. Rs. 2/- per share (Interim Dividend @ 60% i.e. Rs. 3/- per share already paid) for the year 2009-10. (3) Re-appointment of Dr. K. Ramachandran, Dr. P.L. Sanjeev Reddy and Mr.P. Sarath Chandra Reddy as Directors of the Company. (4) Re-appointment of S.R. Batliboi & Associates, as Statutory Auditors of the Company. Further the final dividend declared at the meeting will be paid to the shareholders on September 28, 2010.
Aug 2010
16 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Aug · Meeting
Board of Directors of the Company at its meeting held on August 05, 2010 has inter-alia considered and approved the following: (1) To convene the Annual General Meeting of the Company on September 23, 2010.(2) The Register of Members and Share Transfer Books of the Company will be closed from September 15, 2010 to September 23, 2010 (both days inclusive) for the purpose of Annual General Meeting and for payment of dividend for the year 2009-10.5 Aug · Results
Consolidated Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 92225 lacs for quarter ending on 30-JUN-2010 against Rs. 80965 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 5150 lacs for the quarter ending on 30-JUN-2010 against Rs. 16657 lacs for the quarter ending on 30-JUN-2009.5 Aug · Results
Standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 86751 lacs for quarter ending on 30-JUN-2010 against Rs. 75223 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 6334 lacs for the quarter ending on 30-JUN-2010 against Rs. 12611 lacs for the quarter ending on 30-JUN-2009.